Switch theme
Sign up to access all valuation multiples
Carasent AB (publ) Formerly Carasent AB is in the businesses that develop entrepreneurial and e-health solutions. It delivers cloud based EHR solutions, with Webdoc as the platform, and a ecosystem of platform services, including solutions for patient communication and business intelligence. The ecosystem of solutions makes Carasent a one-stop shop for clinics and can cover all needs.
1997
165
LTM Revenue $29.0M
LTM EBITDA $3.7M
$145M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Carasent has a last 12-month revenue of $29.0M and a last 12-month EBITDA of $3.7M.
In the most recent fiscal year, Carasent achieved revenue of $27.3M and an EBITDA of $1.2M.
Carasent expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Carasent valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $24.2M | $27.3M | XXX | XXX | XXX |
| Gross Profit | $16.0M | $19.6M | XXX | XXX | XXX |
| Gross Margin | 66% | 72% | XXX | XXX | XXX |
| EBITDA | $0.3M | $1.2M | XXX | XXX | XXX |
| EBITDA Margin | 1% | 4% | XXX | XXX | XXX |
| Net Profit | $3.1M | -$4.6M | XXX | XXX | XXX |
| Net Margin | 13% | -17% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Carasent's stock price is SEK 23 (or $2).
Carasent has current market cap of SEK 1.7B (or $165M), and EV of SEK 1.5B (or $145M).
See Carasent trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $145M | $165M | XXX | XXX | XXX | XXX | $-0.04 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Carasent has market cap of $165M and EV of $145M.
Carasent's trades at 5.0x LTM EV/Revenue multiple, and 38.7x LTM EBITDA.
Analysts estimate Carasent's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Carasent and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $145M | XXX | XXX | XXX |
| EV/Revenue | 5.3x | XXX | XXX | XXX |
| EV/EBITDA | 125.1x | XXX | XXX | XXX |
| P/E | -39.2x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -282.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpCarasent's NTM/LTM revenue growth is 23%
Carasent's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Carasent's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Carasent's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Carasent and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 13% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 4% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 300% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 27% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 0% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 20% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 102% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Carasent acquired XXX companies to date.
Last acquisition by Carasent was XXXXXXXX, XXXXX XXXXX XXXXXX . Carasent acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Carasent founded? | Carasent was founded in 1997. |
| Where is Carasent headquartered? | Carasent is headquartered in Sweden. |
| How many employees does Carasent have? | As of today, Carasent has 165 employees. |
| Is Carasent publicy listed? | Yes, Carasent is a public company listed on STO. |
| What is the stock symbol of Carasent? | Carasent trades under CARA ticker. |
| When did Carasent go public? | Carasent went public in 2012. |
| Who are competitors of Carasent? | Similar companies to Carasent include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
| What is the current market cap of Carasent? | Carasent's current market cap is $165M |
| What is the current revenue of Carasent? | Carasent's last 12-month revenue is $29.0M. |
| What is the current EBITDA of Carasent? | Carasent's last 12-month EBITDA is $3.7M. |
| What is the current EV/Revenue multiple of Carasent? | Current revenue multiple of Carasent is 5.0x. |
| What is the current EV/EBITDA multiple of Carasent? | Current EBITDA multiple of Carasent is 38.7x. |
| What is the current revenue growth of Carasent? | Carasent revenue growth between 2023 and 2024 was 13%. |
| Is Carasent profitable? | Yes, Carasent is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
